Understanding Activation Rate and Its Importance in Clinical Research Sales

Activation rate, in the context of clinical-research pharmaceuticals sales, refers to the percentage of newly signed customers who actively engage with your service or product within a specified timeframe. For a subscription-based service offering clinical trial management software or pharmaceutical data access, activation means customers start using the platform regularly, contributing data, or interacting with support.

Improving this rate matters because it directly affects customer retention. If clients never properly activate, they're more likely to churn. A 2024 report by PharmaSales Insights showed companies with activation rates above 60% retain 25% more customers year-over-year compared to those below 40%.

The Specific Challenge for Entry-Level Sales

Entry-level sales professionals often face the challenge of moving beyond securing the initial contract to ensuring customers find ongoing value. Unlike one-off pharmaceutical equipment sales, clinical-research companies increasingly rely on subscription or recurring revenue models. This means activation is not a one-time event but a process that requires monitoring and support.

You might have just closed a deal for a clinical trial data analytics platform subscription, but if the customer doesn’t start using the platform actively—uploading trial data, generating reports—the deal’s at risk.

Case Context: Subscription Model Optimization to Enhance Activation

Consider a mid-sized clinical-research company that provides a subscription-based software tool designed for pharmaceutical trial coordinators. The product helps manage patient recruitment data, protocol amendments, and regulatory submissions.

The Problem

The sales team noted that while they closed 100 new subscriptions quarterly, only 45% of customers fully activated within 30 days. This low activation rate led to a 30% churn rate within six months.

What Was Tried

The company’s entry-level sales reps were encouraged to shift focus from just signing contracts to nurturing customer activation—starting with subscription model optimization. The following activities were rolled out:

1. Segmented Onboarding Paths: Different onboarding emails and walkthroughs were created for small trial sites vs. large pharma clients.
2. Usage Triggers for Outreach: Sales reps were notified if a client failed to log in or engage with certain features within 7 days.
3. Feedback Collection Using Zigpoll: After initial product demos and onboarding emails, clients received surveys to identify potential blockers.
4. Flexible Subscription Plans: Offering tiered subscription options based on how many active trial sites the client managed, with incentives for upgrading.

Step-By-Step Activation Rate Improvement Process

Step 1: Map the Customer Journey Beyond Sale

You need to understand every touchpoint from contract signing to first successful use. For example, for a Pharma trial manager, first use might mean uploading a patient data set and running a compliance report.

How to do this:

• Use CRM reports to track customer activity post-sale.
• Identify common drop-off points (e.g., signing contract but no login within 3 days).
• Engage with Customer Success or Onboarding teams to understand barriers.

Gotcha:
Don’t assume all customers activate at the same pace. Some large pharma clients may take longer due to internal approvals.

Step 2: Customize Engagement Based on Subscription Type

Subscriptions differ—some clients pay monthly for limited features; others opt for annual, full-suite services.

How to do this:

• Segment clients by subscription level.
• Tailor onboarding sequences accordingly. For example, a small biotech firm may benefit from a basic tutorial, whereas a multinational pharma company may need dedicated account management.

Example:
One team that introduced segmented onboarding saw activation jump from 2% to 11% within the first 30 days for small biotech customers.

Step 3: Proactively Monitor and Intervene on Inactivity

Waiting for customers to ask for help is too late.

How to do this:

• Use your CRM or product analytics tools to flag accounts with no action after signup.
• Sales reps reach out personally within the first week.
• Offer additional training sessions or troubleshooting.

Tool Options:
Besides Zigpoll for feedback, consider SurveyMonkey or Qualtrics for more in-depth customer insights into activation hurdles.

Limitation:
In larger organizations, too frequent outreach can annoy customers, so calibrate touchpoints carefully.

Step 4: Optimize Subscription Plans for Flexibility and Scaling

Rigid subscription models may deter customers from activating fully, especially if they fear overpaying.

How to do this:

• Introduce tiered plans reflecting actual usage.
• Add incentives like discounts for upgrading within 90 days.
• Consider trial extensions or bundled services.

Example Data:
A 2023 Pharma Subscription Trends Survey found that 68% of clinical-research companies that offered flexible subscription tiers saw a 15% higher activation rate.

Results Observed

After six months of these strategies, the company reported the following:

Lessons Learned and What Didn’t Work

What Worked

• Early, segmented engagement helped customers see value immediately.
• Active monitoring and personal follow-up reduced stalled activations.
• Flexible subscription options lowered barriers to entry and encouraged scaling over time.
• Using quick surveys like Zigpoll enabled rapid identification of blockers without overwhelming clients.

What Didn’t

• Overloading clients with multiple surveys or emails led to disengagement.
• Automation without human check-ins missed nuances in large pharma clients’ complex approval processes.
• Trying to force activation too quickly backfired with some conservative customers preferring a longer evaluation timeline.

Tips for Entry-Level Sales Professionals

• Collaborate closely with Customer Success teams to track activation metrics.
• Use CRM data to identify inactive customers early and set reminders for outreach.
• Learn the subscription tiers well and explain benefits clearly during onboarding.
• Incorporate at least one survey tool like Zigpoll to gather customer feedback post-sale.
• Be patient with clients managing regulatory hurdles or internal review processes.

Final Thoughts

Improving activation rates in clinical-research pharmaceuticals sales is not about pushing harder for usage but about guiding customers thoughtfully through the subscription experience. Subscription model optimization plays a critical role, by accommodating varying client needs and allowing entry-level sales reps to maintain customer engagement after the initial sale.

By implementing segmented onboarding, proactive outreach, flexible plans, and customer feedback loops, sales teams can both reduce churn and increase customer loyalty in this specialized industry. Just remember the process requires balance—persistence combined with sensitivity to the complexities pharmaceutical clients face.